PDF) Quality Assessment of Investigational Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical Trials Office
Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documents - Journal of Clinical Epidemiology
European Regulatory Framework and General Path to Market for ATMPs
Pharmaceuticals | Free Full-Text | Quality Assessment of Investigational Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical Trials Office | HTML
New documents in EudraLex Volume 10 Clinical trials guidelines including an updated CTA form
The Parallel Universes of Eudralex Vol 10 – JoBurmester.com
PDF) Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals | Clemens Decristoforo - Academia.edu
Scan to personal folder
Commission Guideline — Guidance on posting and publication of result-related information on clinical trials in relation to the
Update on the Clinical Trials Regulation (EU) No 536/2014 - Key developments
PPT - REVISION OF EUDRALEX VOL. 4 - GMP Luisa Stoppa, Ph.D. Inspection and Certification Department PowerPoint Presentation - ID:6720277
Frontiers | Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective
GMP for IMPs in View of the Revision of the EU Clinical Trial Provisions
GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC Version 5 10/02/2022
GUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON THE CONDUCT OF GCP INSPECTIONS BY COMPETENT AUTHORITIES OF THE DIFFERENT
Frontiers | Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience
DIRECTIVE” 2001/20/EC
New documents in EudraLex Volume 10 Clinical trials guidelines including an updated CTA form
PDF) Clinical trial disclosure and transparency: Regulation EU No. 536/2014 Public disclosure at the clinical trial level
AIFA notice (update of the AIFA notice published on 12 March 2020) Clinical trials' management in Italy during the COVID-19 (
EudraLex - Volume 10 - Clinical trials guidelines UPDATED
Clinical Trials Toolkit Trial Supplies - PDF Free Download
REVISION OF EUDRALEX VOL. 4 - GMP - ppt download
Updated Draft Q&As for Clinical Trials Regulation 536/2014 released in EudraLex Volume 10
New documents in EudraLex Volume 10 Clinical trials guidelines including an updated CTA form
page 1 of 3 Version 1.0, 26 March 2020 Supplementary recommendations to the document European Guidance on the Management of Cl
Guidance and Q&As - EMA
Guidance for the Submission and Conduct of Clinical Trials (CT) with Medicinal Products - PDF Free Download
